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Reirradiation of late local recurrences of carcinoma
of the cervix after primary radiotherapy
Grzegorz Panek
P u r p o s e. To assess long term results of reirradiation of late local recurrences of carcinoma of the cervix.
M a t e r i a l  a n d  m e t h o d s. Between 1980 and 1995, 55 patients received reirradiation for local recurrence of carcinoma
of the cervix. The time gap between primary radiotherapy and the diagnosis of local recurrence was at least 10 years (range 10-
-32 years). Secondary radiotherapy consisted of brachytherapy, external beam irradiation or combination of both methods, de-
pending on the tumor site and volume. Low dose rate Ra226 and Cs137 sources were used for brachytherapy with the dose of
18-62 Gy at 0,5 cm below the tumor base. Two field technique was used for external beam irradiation with the dose 20-50 Gy.
The follow–up ranged from 10 to 142 months. Survival curves were calculated using the Kaplan-Meier method for patients with
respect to the site of the tumor. The tolerance of reirradiation was also evaluated.
R e s u l t s. The 5- and 3-year survival in the analyzed group was 9.1% and 27.3% respectively. The 5-year survival for 24 pa-
tients with the tumor limited to the cervix and vagina was 20.8%. The risk of serious complications of reirradiation was high
at 18% with one lethal complication (6.7%).
C o n c l u s i o n s. The results of the study confirme the effectiveness of reirradiation of small volume central recurrences limi-
ted to the vaginal apex. A long term cure can be achieved in this subset of patients. Only palliative result can be expected in the
locally advanced cases with parametrial extension of the tumor. Because of high incidence of severe complications, reirradia-
tion should be considered primarily in patients medically unfit for radical exenterative surgery.
Wyniki powtórnego napromieniania póênych nawrotów miejscowych
raka szyjki macicy po pierwotnej radioterapii
C e l e m pracy by∏a ocena wyników odleg∏ych powtórnego napromieniania nawrotów miejscowych inwazyjnego raka szyjki ma-
cicy po pierwotnej radioterapii.
M a t e r i a ∏  i m e t o d y. W okresie 1980-1995 55 chorych przeby∏o powtórne napromienianie z powodu póênych nawrotów
miejscowych raka szyjki macicy po pierwotnej radioterapii. Do powtórnego napromieniania kwalifikowano chore z rozpozna-
nà wznowà obejmujàcà pochw´ lub przymacicza rozpoznane w okresie minimum 10 lat po zakoƒczeniu leczenia pierwotne-
go. Leczenie wznów polega∏o na zastosowaniu teleradioterapii w dawce 20-50Gy, brachyterapii dojamowej z wykorzystaniem
iztopu Ra-226 lub Cs-137 w dawce 18-62 Gy. Okres obserwacji po leczeniu wynosi∏ od 10 do 142 miesi´cy. Metodà Kaplana-
-Meiera obliczono krzywe prze˝ycia dla chorych z uwzgl´dnieniem lokalizacji nawrotu. W ocenie wyników dokonano oceny
tolerancji leczenia - cz´stoÊci i typów wczesnych odczynów popromiennych.
W y n i k i. Odsetek prze˝yç 5-letnich wyniós∏ 9,1%, a 3-letnich 27,3%. SpoÊród 24 chorych ze wznowà centralnà ograniczo-
nà do pochwy okres 5 lat prze˝y∏o 20,8% leczonych. Ocena tolerancji leczenia potwierdzi∏a wysokie ryzyko Êrednich i ci´˝kich
odczynów popromiennych wynoszàce 18%. Zaobserwowano jedno powik∏anie Êmiertelne - 6,7% ogó∏u leczonych.
W n i o s k i. DoÊwiadczenia z powtórnym napromienianiem póênych nawrotów raka szyjki macicy potwierdzajà skutecz-
noÊç tej metody w przypadku wznów centralnych ograniczonych do pochwy. Uzyskany odsetek prze˝yç 5-letnich 20,8% zbli-
˝ony jest do wyników uzyskiwanych po operacjach wytrzewiajàcych.
EfektywnoÊç powtórnego napromieniania w przypadku nawrotów w przymaciczach jest ograniczona i ma charakter wy-
∏àcznie paliatywny. Powtórne napromienianie jest interesujàcà opcjà terapeutycznà dla chorych, które nie kwalifikujà si´ do
radykalnych operacji egzenteracyjnych lub nie akceptujà tej metody leczenia.
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Introduction
Local recurrences are the major cause of treatment failu-
re in patients with invasive carcinoma of the cervix. They
occur in about 15-20% of women with stage I disease tre-
ated either with surgery or radiotherapy. Their incidence
increases to 40-60% in patients with stage II and III [1].
The risk of developing a recurrence is the highest within
the first two years after primary treatment. Only 2% of
women who survived a period of 5 years subsequently
develop a local failure [2]. The diagnosis of local recurren-
ce forms a very challenging clinical problem to the gyne-
cologist oncologist. It is generally agreed that recurrent di-
sease after radical radiotherapy should be treated with
surgery. The 5-year survival rate of 30-40% can be achie-
ved with exenterative surgery for the treatment of central
recurrences [3, 4]. The application of radical surgery in
patients with late recurrences is often limited by a com-
promised general condition and poor acceptance of exen-
teration. For them reirradiation is the only reasonable
treatment option. The results of secondary radiotherapy
of pelvic relapses of cervical cancer show, that 25-35% of
patients can be cured by a combination of external beam
irradiation and brachytherapy [5-9].
The purpose of this retrospective study is to present
a 15-year experience in reirradiation of local recurren-
ces of carcinoma of the cervix.
Materials and methods
From January 1980 to December 1995, 55 cases of late recurrent
carcinoma of the cervix were treated at the Department of Gyne-
cologic Oncology of Cancer Center and Institute of Oncology.
All patients were primarily treated with radiotherapy consisting
of external beam irradiation and brachytherapy. For teletherapy
cobalt-60 machines and 4-18MeV linear accelerators were used.
The pelvic dose ranged from 42 to 46Gy given in 21-24 frac-
tions. The fraction dose was 1.8-2.0Gy. The intracavitary treat-
ment consisted of two low dose rate insertions of Radium 226, or
Cesium 137. The dose delivered to point A was 45-55Gy. To
define a late local recurrence of cervical cancer the following cri-
teria had to be met: the presence of the lesion with microscopic
features similar to the primary tumor of the cervix, minimal di-
sease free survival of 10 years after completion of primary radio-
therapy. The sites of recurrent tumor were vaginal apex - 24 ca-
ses and vagina with parametrial extention of the disease - 31
cases. Secondary irradiation was planned according to the site of
the recurrence, the presence of parametrial involvement, radia-
tion dose and tolerance of primary irradiation. Both intracavita-
ry and interstitial brachytherapy was used for the treatment of
central recurrences limited to the vagina. The dose measured at
5mm below the surface of the mucosa was 20-45Gy. External be-
am irradiation was added to boost the dose of radiation to the
pelvic side wall. The two field technique was used with the dose
to the pelvis of 20-45Gy.
A detailed clinical characteristic of the analyzed group are
presented in Table I.
The follow up ranged from 10 to 96 months. Relapse free
survival was calculated with Kaplan-Meier method for subpopu-
lation of patients with two different localizations of recurrences.
Differences in proportions were evaluated by the Fisher Exact
test. Statistical significance was considered as p<0.05.
Table I. Local recurrences of carcinoma
of the cervix – clinical characteristic
Type of recurrence Time gap between Clinical symptoms
No of patients primary treatment of recurrence
and diagnosis of
recurrence
vagina, cervix 10-29 yrs asymptomatic 5
24 (median 15.8 yrs) bleeding 15
discharge 8
vagina, parametria 10-32 yrs pelvic pain 20
31 (median 17.9 yrs) discharge 11
bleeding 9
leg edema 6
Results
The 3- and 5-year survival rates for the whole analyzed
group were 27.3% (15/55) and 9.7% (5/55), respectively.
In women with the central recurrence limited to the vagi-
na the 5-year survival was 20.8% (5/24) and 3 patients
survived more than 10 years. No long term survivors we-
re observed in patients with parametrial extension of the
recurrence. The survival ranged from 4 to 36 months
(median 17 months) Table II.
The survival curves for two subpopulations of pa-
tients with vaginal only and parametrial recurrence are
presented on Figure 1.
The assessment of tolerance of reirradiation has
shown that in 18% (10/55) of cases the treatment had to
be discontinued because of the presence of acute reaction
from the critical organs. Persistent leucopenia and small
bowel irritation were the most frequent causes of hospita-
lization, treatment delays and in some cases discontinu-
ation of radiotherapy (Table III).
The overall incidence of late complications was 9%
(6/55) and 22% (6/15) in those who survived at least 3
years. Three patients required a surgical intervention to
manage late bowel stricture and occlusion. One patient
Table II. Methods and results of treatment of the late recurrences of cervical cancer
Type of recurrence Method of No of Survival - years
No of patients treatment patients >5 3-5 <3
brachytherapy 9 4 1 5
cervix, vagina brachyth+teletherapy 10 1 7 2
24 teletherapy 5 – 1 4
brachytherapy 6 – 1 5
vagina, parametria brachyth+teletherapy 6 – – 6
31 teletherapy 19 – – 19
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(1,8%) died of acute hemorrhagic cystitis 3 years after
secondary irradiation. No sign of persistent disease was
found on autopsy. The summary of clinical data about
the late complications is presented in Table IV.
Table IV. Late complications of reirradiation
Type of complications No % % of patients
with survival > 3 yrs
proctitis 3/55 5.4 3/15 20.0
skin necrosis 1/55 1.8 1/15 6.7
sigmoid colon
stricture 1/55 1.8 1/15 6.7
haemorrhagic cystitis
(lethal) 1/55 1.8 1/55 6.7
No correlation has been found between the number
of late complications and combined dose of radiation
from primary and secondary radiotherapy.
Discussion
Local recurrences of invasive carcinoma of the cervix are
the most frequent cause of treatment failure. The majori-
ty of them appear within the first 2 years after radiothera-
py or radical surgery. Late recurrences, diagnosed later
than 5 years after primary treatment are a unique clinical
entity. Their incidence is low- 1-2% of all treated patients
and 4-5% cured of the disease and is independent of clini-
cal stage and pathology of the primary tumor [2]. The
etiology of late recurrences is not clear. Some investigators
advocate the existence of the dormant cells which have
a potential to proliferate and to form a recurrent tumor.
These tumors are also considered to be second primary tu-
mors developed in the previously irradiated area. There
some doubts about the role of past history of radiotherapy
as the incidence of late local recurrences is similar in pa-
tients treated primarily with radiotherapy and surgery.
The diagnosis of the late treatment failure bears
a serious prognosis to the patient and poses a difficult
challenge to the gynecologist oncologist.
Traditionally surgery is regarded as the optimal mo-
dality of treatment of recurrent carcinoma of the cervix
after primary radiotherapy. The progress in surgical tech-
nique and postoperative care has resulted in a significant
improvement in the long term results of exenterative sur-
gery. The 5-year survival of about 40% can be expected
for patients with central recurrences treated with periope-
rative mortality of less than 5% [3]. The practical applica-
tion of radical surgery for late recurrences of carcinoma of
the cervix developed many years after primary radiothera-
py is very limited by an advanced age, compromised gene-
ral condition and poor acceptance of radical surgery by
those patients. These limitations make reirradiation the
only reasonable therapy available for the women with la-
te recurrences. The clinical experience with retreatment
of local recurrences with secondary radiotherapy is limi-
ted. Only a few reports on this subject have been publi-
shed in the recent years [7-9]. The overall 5-year survival
of only 9.1% recorded in this series indicates a very serio-
us prognosis in women with locally relapsing carcinoma of
the cervix. Better results were achieved in women with
central recurrence limited to the vagina. The 5-year survi-
val rate of 20.8% was significantly higher than in cases
with parametrial extension of the tumor. The only long
term survivors were the women with the tumor limited to
the vaginal apex. Other authors also confirmed the pro-
gnostic importance of tumor volume and localization [8,
9]. Wang et al. found a significantly higher local control
and survival in patients with recurrences in the upper va-
gina than in the lower vagina. The difference of local
control rate and survival was also significant for tumor
diameter <4cm and >4cm.
Brachytherapy is the principal method of reirradia-
tion of small volume local recurrences of cervical cancer
[9, 11, 12]. The effectiveness of brachytherapy is suppor-
ted by the results of the present study. All long term survi-
vors were treated with intracavitary treatment. Thera-
peutic potential of brachytherapy can be farther improved
by the application of interstitial implants. The local con-
trol rate of about 50% with the incidence of moderate-se-
vere complications of less than 15% can be achieved with
interstitial brachytherapy [11, 12]. A novel approach to
the treatment of local recurrences is the application of
permanent Iodine -125 implants. Sharma et al. [13] ap-
plied this technique to the treatment of locally relapsing
cervical and endometrial cancer. The local control rate
Figure 1. Probability of survival of patients with central recurrence 
(N= 24) and with parametrial involvement (N= 31)
Table III. Early acute complications of reirradiation
Type of reaction No %
diarrhoea with 9/55 16.3
dehydration
acute cystitis 7/55 12.7
acute skin reaction 6/55 10.9
leucopenia 9/55 16.4
discontinuation of
treatment 10/55 18.2
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was 75% with the median survival of 26 months. Previous
experience with reirradiation of recurrences tumors of
different histological types and localization showed a ve-
ry high incidence of severe complications. In the case of
recurrences of cervical cancer the limiting factor was the
tolerance of critical organs like bladder and rectum [14].
Because the mechanisms of tissue repair act more effecti-
vely in the longer time span, the time gap between the ter-
mination of primary radiotherapy and reirradiation in
the most important prognostic factor in predicting tole-
rance of the treatment. More recent clinical observations
confirm the effectiveness of the repair mechanisms even
in the slowly regenerating tissues like the spinal cord allo-
wing a relatively safe reirradiation of the breast, lung,
CNS and pelvic tumors [15, 16].
In the present study time gap from the termination
of primary treatment was an important factor predicting
good tolerance of reirradiation. The incidence of acute re-
actions was 22% and the intensity of side effects finally
led to discontinuation of the treatment in 18% of pa-
tients. Similar rates of early acute reactions and disconti-
nuation of the treatment were presented by other au-
thors [8, 9, 14 ]. The overall incidence of late moderate
and severe complications was 9% and 22% for those who
survived a minimum of 3 years and overall mortality was
6.7%. Other investigators reported similar results stressing
the importance of a meticulous analysis of the important
clinical factors before the treatment is initiated [7, 9, 14].
In order to lower the risk of developing severe complica-
tions modern imaging techniques should be used to defi-
ne the tumor extent more precisely and to limit the dose
to the critical organs. The use of conformal external beam
irradiation and interstitial brachytherapy may contribute
to the better tolerance of reirradiation [14, 17].
Our experience confirms the complexity of the pro-
blem of reirradiation of recurrent carcinoma of the cervix
after primary radiotherapy. Many clinical parameters like
tumor localization, volume, relation to the critical or-
gans, radiation dose at primary treatment and time gap
from primary treatment have to be carefully analyzed be-
fore the decision to reirradiate is made. The results of
this study confirm the value of retreatment of late local
recurrences of carcinoma of the cervix. The long term
survival after reirradiation similar to the results of radical
surgery can be expected for small volume, central recur-
rences limited to the vaginal apex. The results of treat-
ment of local recurrences with parametrial involvement
were less satisfactory and only palliative effect was obta-
ined.
These results indicate the need for further studies on
earlier detection and better methods of treatment of late
recurrences of carcinoma of the cervix.
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